Dr Prithwijit Moitra

Associate Consultant – Radiation Oncology

MBBS | MD (Radiation Oncology)

January 1, 2021

Connect with Dr Prithwijit Moitra

Top Areas of Expertise

Stereotactic Radiosurgery (SRS)
Stereotactic Body Radiotherapy (SBRT)
Intensity-Modulated Radiotherapy (IMRT)
Volumetric Modulated Arc Therapy (VMAT)
Brachytherapy (Intracavitary & Interstitial)
Total Body & Total Skin Radiation Therapies

Top Treatments Offered

SRS & SBRT (Brainlab, Novalis TX)
IMRT & VMAT (Varian TrueBeam, Tomotherapy, Halcyon)
Total Body Irradiation (TBI)
Total Skin Electron Beam Therapy (TSEBT)
3D Conformal Radiotherapy (3D-CRT)
Conventional 2D Radiotherapy (Cobalt)
Intracavitary, Intraluminal & Interstitial Brachytherapy

About Dr Prithwijit Moitra

Dr. Prithwijit Moitra is a highly skilled Associate Consultant in Radiation Oncology at Manipal Hospitals, Rangapani, with strong academic credentials and focused clinical expertise. A Gold Medalist from the Homi Bhabha National Institute and recipient of the Agarwal Gold Medal from Tata Memorial Hospital, he is known for delivering advanced, precision-based radiation treatments. His practice emphasises patient safety, treatment accuracy, and evidence-based oncology care across multiple cancer subspecialties.

Educational Qualification

MBBS – Medical College, Kolkata
MD (Radiation Oncology) – Homi Bhabha National Institute (HBNI)
- Awarded Gold Medal for academic excellence
Agarwal Gold Medal – Tata Memorial Hospital (TMC)

Professional Experience

Associate Consultant – Radiation Oncology, Manipal Hospitals, Rangapani
Over 4 years of experience in advanced radiation oncology
Active management of Neuro, Head & Neck, Breast, and Gynaecological cancers
Experience in clinical trial development and protocol-driven oncology care

Awards & Achievements

Gold Medal in Radiation Oncology – HBNI
Agarwal Gold Medal – Tata Memorial Hospital (TMC)

Talks & Publications

Moitra P et al: Temozolomide-Induced Myelotoxicity And Single Nucleotide Polymorphisms In The MGMT Gene In Patients With Adult Diffuse Glioma: A Single-Institutional Pharmacogenetic Study. J Neurooncol. 2022 Doi:10.1007s11060-022-03944-6.
Moita P et al: MGMT Gene Polymorphisms in Patients With Severe Haematological Toxicity Treated With Temozolomide For Adult Diffuse Gliomas: Results From A Tertiary-Care Comprehensive Cancer Centre. Journal Of Clinical Oncology 39:E14032, 2021. Doi: 10.1200/Jco. 2021.39.15_suppl.E14032.
Conference Presentation and Workshop: Oral Presentation In the Annual Conference Of the Association Of Radiation Oncologists In India – Maharashtra State Chapter Held On 19-12-2020.
Attendee Asia Pacific Clinical Oncology Research Development (Acord) 2022 Online Workshop For Designing Randomised Controlled Trials.